Market Overview:
The global hyaluronic acid-based biomaterials market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing demand for cosmetic grade and food grade hyaluronic acid-based biomaterials. In addition, the rising demand for medical hygiene applications is also contributing to the growth of this market. The global hyaluronic acid-based biomaterials market by type is segmented into cosmetic grade, food grade, and pharmaceutical grade. The cosmetic grade segment is expected to grow at a CAGR of 8% from 2018 to 2030. This growth can be attributed to the increasing demand for dermal fillers and anti-aging products that contain hyaluronic acid as an ingredient.
Product Definition:
Hyaluronic acid-based biomaterials are materials that are composed of, or contain, hyaluronic acid. Hyaluronic acid is a naturally occurring substance found in the human body that helps to lubricate and cushion joints. Hyaluronic acid-based biomaterials have been used in a variety of medical applications, including as implants and fillers for cosmetic surgery.
Cosmetic Grade:
Cosmetic grade hyaluronic acid is used in the manufacturing of skincare, haircare, and oral care products. It has a high viscosity that allows it to be easily incorporated into cosmetic formulations. Cosmetic-grade HA is widely utilized as an additive for enhancing the properties of other cosmetic ingredients such as fillers and binders.
Food Grade:
Food-grade hyaluronic acid is used in the manufacturing of biocompatible and biodegradable medical implants. It has a wide range of applications including tissue engineering, drug delivery systems, cell replacement therapy, bone reconstruction & repair and artificial ligaments & tendons. The global food-grade hyaluronic acid market size was valued at USD 31 million in 2016 which is anticipated to grow at a CAGR of XX% over the forecast period.
Application Insights:
The medical hygiene segment dominated the global market and accounted for a revenue share of over 40.0% in 2017. The increasing prevalence of chronic diseases, such as cardiovascular, diabetes mellitus, cancer and osteoarthritis is expected to boost the demand for hyaluronic acid-based biomaterials in medical hygiene applications during the forecast period.
Hyaluronic acid-based biomaterials are used in wound management owing to their excellent properties including tissue regeneration and angiogenesis inhibition that help reduce postoperative infections after surgery or trauma wounds healing process. These materials have also been proven effective in treating pressure ulcers as they promote skin grafting by improving blood supply to the area surrounding a wound thereby accelerating healing processes.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of companies coupled with high demand for minimally invasive surgeries and advanced medical devices is expected to drive the regional market over the forecast period. In addition, increasing prevalence of osteoarthritis and other joint-related problems are anticipated to boost product penetration in this region.
Asia Pacific is expected to witness significant growth during the forecast period owing to rising awareness about cosmetic applications among consumers from China, Japan, South Korea, Singapore and India. Growing geriatric population coupled with increasing disposable income will also support regional growth over next eight years.
Growth Factors:
- Increasing demand for minimally invasive surgeries: The global market for minimally invasive surgeries is expected to grow at a CAGR of 6.5% from 2016 to 2021. This is primarily due to the increasing number of aging population and rising prevalence of chronic diseases. Minimally invasive surgeries offer several benefits over traditional open surgery such as shorter hospital stay, reduced pain, and faster recovery time. This is likely to drive the demand for hyaluronic acid-based biomaterials in the coming years.
- Growing use of hyaluronic acid-based biomaterials in regenerative medicine: Regenerative medicine involves repairing, restoring, or replacing damaged tissues or organs using stem cells or other cell therapies. Hyaluronic acid-based biomaterials are increasingly being used in regenerative medicine due to their ability to promote cell growth and migration. They are also effective in delivering drugs and other therapeutic agents directly into the target tissue site. This is likely to boost the growth of the hyaluronic acid-based biomaterials market in the coming years
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyaluronic Acid-based Biomaterials Market Research Report
By Type
Cosmetic Grade, Food Grade, Pharmaceutical Grade
By Application
Medical Hygiene, Plastic Surgery, Health Products, Cosmetic
By Companies
Kewpie, CPN, Shiseido, Novozymes, Bloomage BioTechnology, Shandong Galaxy Bio-Tech, China Eastar, FocusChem Biotech, Shandong Topscience Biotech, QuFu GuangLong Biochem, Weifang Lide Bioengineering, Jiangsu Haihua Biotech, Qufu Liyang Biochem Industrial, Tongxiang Hengji biotechnology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Hyaluronic Acid-based Biomaterials Market Report Segments:
The global Hyaluronic Acid-based Biomaterials market is segmented on the basis of:
Types
Cosmetic Grade, Food Grade, Pharmaceutical Grade
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical Hygiene, Plastic Surgery, Health Products, Cosmetic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Kewpie
- CPN
- Shiseido
- Novozymes
- Bloomage BioTechnology
- Shandong Galaxy Bio-Tech
- China Eastar
- FocusChem Biotech
- Shandong Topscience Biotech
- QuFu GuangLong Biochem
- Weifang Lide Bioengineering
- Jiangsu Haihua Biotech
- Qufu Liyang Biochem Industrial
- Tongxiang Hengji biotechnology
Highlights of The Hyaluronic Acid-based Biomaterials Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cosmetic Grade
- Food Grade
- Pharmaceutical Grade
- By Application:
- Medical Hygiene
- Plastic Surgery
- Health Products
- Cosmetic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyaluronic Acid-based Biomaterials Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyaluronic acid-based biomaterials are a class of materials that are composed of hyaluronic acid molecules. These materials can be used to help restore and maintain tissue health, and they have been shown to be effective in treating a variety of medical conditions. Hyaluronic acid-based biomaterials are often used in surgeries to help repair damaged tissues, and they have also been studied as potential treatments for diseases such as arthritis, cancer, and diabetes.
Some of the major companies in the hyaluronic acid-based biomaterials market are Kewpie, CPN, Shiseido, Novozymes, Bloomage BioTechnology, Shandong Galaxy Bio-Tech, China Eastar, FocusChem Biotech, Shandong Topscience Biotech, QuFu GuangLong Biochem, Weifang Lide Bioengineering, Jiangsu Haihua Biotech, Qufu Liyang Biochem Industrial, Tongxiang Hengji biotechnology.
The hyaluronic acid-based biomaterials market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hyaluronic Acid-based Biomaterials Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hyaluronic Acid-based Biomaterials Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hyaluronic Acid-based Biomaterials Market - Supply Chain
4.5. Global Hyaluronic Acid-based Biomaterials Market Forecast
4.5.1. Hyaluronic Acid-based Biomaterials Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hyaluronic Acid-based Biomaterials Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hyaluronic Acid-based Biomaterials Market Absolute $ Opportunity
5. Global Hyaluronic Acid-based Biomaterials Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Type
5.3.1. Cosmetic Grade
5.3.2. Food Grade
5.3.3. Pharmaceutical Grade
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hyaluronic Acid-based Biomaterials Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Application
6.3.1. Medical Hygiene
6.3.2. Plastic Surgery
6.3.3. Health Products
6.3.4. Cosmetic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hyaluronic Acid-based Biomaterials Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hyaluronic Acid-based Biomaterials Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hyaluronic Acid-based Biomaterials Demand Share Forecast, 2019-2026
9. North America Hyaluronic Acid-based Biomaterials Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Application
9.4.1. Medical Hygiene
9.4.2. Plastic Surgery
9.4.3. Health Products
9.4.4. Cosmetic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Type
9.7.1. Cosmetic Grade
9.7.2. Food Grade
9.7.3. Pharmaceutical Grade
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hyaluronic Acid-based Biomaterials Demand Share Forecast, 2019-2026
10. Latin America Hyaluronic Acid-based Biomaterials Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Application
10.4.1. Medical Hygiene
10.4.2. Plastic Surgery
10.4.3. Health Products
10.4.4. Cosmetic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Type
10.7.1. Cosmetic Grade
10.7.2. Food Grade
10.7.3. Pharmaceutical Grade
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hyaluronic Acid-based Biomaterials Demand Share Forecast, 2019-2026
11. Europe Hyaluronic Acid-based Biomaterials Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Application
11.4.1. Medical Hygiene
11.4.2. Plastic Surgery
11.4.3. Health Products
11.4.4. Cosmetic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Type
11.7.1. Cosmetic Grade
11.7.2. Food Grade
11.7.3.Pharmaceutical Grade
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hyaluronic Acid-based Biomaterials Demand Share, 2019-2026
12. Asia Pacific Hyaluronic Acid-based Biomaterials Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Application
12.4.1. Medical Hygiene
12.4.2. Plastic Surgery
12.4.3. Health Products
12.4.4. Cosmetic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Type
12.7.1. Cosmetic Grade
12.7.2. Food Grade
12.7.3. Pharmaceutical Grade
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hyaluronic Acid-based Biomaterials Demand Share, 2019-2026
13. Middle East & Africa Hyaluronic Acid-based Biomaterials Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Application
13.4.1. Medical Hygiene
13.4.2. Plastic Surgery
13.4.3. Health Products
13.4.4. Cosmetic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hyaluronic Acid-based Biomaterials Market Size and Volume Forecast by Type
13.7.1. Cosmetic Grade
13.7.2. Food Grade
13.7.3. Pharmaceutical Grade
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hyaluronic Acid-based Biomaterials Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hyaluronic Acid-based Biomaterials Market: Market Share Analysis
14.2. Hyaluronic Acid-based Biomaterials Distributors and Customers
14.3. Hyaluronic Acid-based Biomaterials Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Kewpie
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CPN
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Shiseido
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novozymes
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bloomage BioTechnology
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Shandong Galaxy Bio-Tech
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. China Eastar
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. FocusChem Biotech
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Shandong Topscience Biotech
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. QuFu GuangLong Biochem
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Weifang Lide Bioengineering
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Jiangsu Haihua Biotech
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Qufu Liyang Biochem Industrial
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Tongxiang Hengji biotechnology
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
